Related Experiment Video
Updated: May 7, 2026
09:14
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells
A Chanut1, F Duguet1, A Marfak1
1CNRS-UMR-7276, University of Limoges, and CHU Dupuytren, Laboratory of Hematology, Limoges, France.
Leukemia
|September 24, 2013
Summary
RelA activation promotes survival and growth in Epstein-Barr virus (EBV)-transformed B cells, while RelB activity is repressed by RelA. This cross-inhibition highlights RelA
Area of Science:
- Molecular Biology
- Immunology
- Virology
Background:
- Epstein-Barr virus (EBV) transformation of B cells involves complex signaling pathways.
- Nuclear factor-kappa B (NF-κB) subunits, RelA and RelB, play critical roles in cellular processes.
- Understanding the interplay between RelA and RelB is crucial for EBV-associated B-cell malignancies.
Purpose of the Study:
- To elucidate the distinct and overlapping functions of RelA and RelB NF-κB subunits in EBV-transformed B cells.
- To investigate the regulatory cross-talk and reciprocal inhibition between RelA and RelB.
- To identify transcriptional targets and functional pathways regulated by RelA and RelB.
Main Methods:
- Utilized EBV-immortalized B-cell models with regulatable RelA and RelB.
- Assessed cell survival, growth, and DNA binding activity.
- Performed gene expression profiling to identify transcriptional targets.
Main Results:
- RelA activation significantly enhanced survival and cell growth.
- RelB activity was induced secondary to RelA and exhibited reciprocal inhibition.
- RelA and RelB regulated distinct sets of genes involved in metabolism, cell cycle, apoptosis, and immune response.
Conclusions:
- RelA is a pivotal regulator in EBV-transformed B cells, controlling survival and growth.
- A cross-inhibitory mechanism exists between RelA and RelB, with RelB subordinated to RelA.
- RelA's central role suggests its potential as a therapeutic target in EBV-associated B-cell malignancies.
Related Concept Videos
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
00:42Cross-reactivity
Overview
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...